Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 1
2011 3
2012 1
2013 1
2015 1
2016 1
2018 2
2019 9
2020 6
2021 6
2022 2
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study.
Granit V, Benatar M, Kurtoglu M, Miljković MD, Chahin N, Sahagian G, Feinberg MH, Slansky A, Vu T, Jewell CM, Singer MS, Kalayoglu MV, Howard JF Jr, Mozaffar T; MG-001 Study Team. Granit V, et al. Among authors: miljkovic md. Lancet Neurol. 2023 Jul;22(7):578-590. doi: 10.1016/S1474-4422(23)00194-1. Lancet Neurol. 2023. PMID: 37353278 Free PMC article. Clinical Trial.
Cytokines in the Treatment of Cancer.
Conlon KC, Miljkovic MD, Waldmann TA. Conlon KC, et al. Among authors: miljkovic md. J Interferon Cytokine Res. 2019 Jan;39(1):6-21. doi: 10.1089/jir.2018.0019. Epub 2018 Jun 11. J Interferon Cytokine Res. 2019. PMID: 29889594 Free PMC article. Review.
IL-15 in the Combination Immunotherapy of Cancer.
Waldmann TA, Dubois S, Miljkovic MD, Conlon KC. Waldmann TA, et al. Among authors: miljkovic md. Front Immunol. 2020 May 19;11:868. doi: 10.3389/fimmu.2020.00868. eCollection 2020. Front Immunol. 2020. PMID: 32508818 Free PMC article. Review.
Paxlovid: A Regulatory Gamble.
Miljković MD, Prasad V. Miljković MD, et al. Am J Med. 2023 Apr;136(4):336-338. doi: 10.1016/j.amjmed.2022.12.017. Epub 2023 Jan 3. Am J Med. 2023. PMID: 36608747 No abstract available.
T-cell lymphomas: A 5-body problem.
Miljkovic MD. Miljkovic MD. Semin Hematol. 2021 Apr;58(2):67-69. doi: 10.1053/j.seminhematol.2021.03.002. Epub 2021 Mar 22. Semin Hematol. 2021. PMID: 33906723 No abstract available.
Engineering CAR-T therapies for autoimmune disease and beyond.
English EP, Swingler RN, Patwa S, Tosun M, Howard JF Jr, Miljković MD, Jewell CM. English EP, et al. Among authors: miljkovic md. Sci Transl Med. 2024 Oct 30;16(771):eado2084. doi: 10.1126/scitranslmed.ado2084. Epub 2024 Oct 30. Sci Transl Med. 2024. PMID: 39475572 Review.
Transforming bioengineering with unbiased teams and tools.
Jewell CM, Miljković MD, Oakes RS. Jewell CM, et al. Among authors: miljkovic md. Nat Rev Bioeng. 2023 Mar 28:1-3. doi: 10.1038/s44222-023-00058-0. Online ahead of print. Nat Rev Bioeng. 2023. PMID: 37359775 Free PMC article.
Interactions between direct anticoagulants and chemotherapy.
Sorigue M, Sarrate E, Miljkovic MD. Sorigue M, et al. Among authors: miljkovic md. Ann Oncol. 2019 Jul 1;30(7):1170. doi: 10.1093/annonc/mdz137. Ann Oncol. 2019. PMID: 31046105 Free PMC article. No abstract available.
Cancer Drug Price and Novelty in Mechanism of Action.
Miljkovic MD, Tuia J, Olivier T, Haslam A, Prasad V. Miljkovic MD, et al. JAMA Netw Open. 2023 Dec 1;6(12):e2347006. doi: 10.1001/jamanetworkopen.2023.47006. JAMA Netw Open. 2023. PMID: 38079171 Free PMC article.
37 results